Simplex Trading
IMUX icon

Simplex Trading’s Immunic IMUX Stock Holding History

Simplex Trading’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$167K Buy
15,060
+2,400
+19% +$21.5K ﹤0.01% 4512
2025
Q4 		$67.6K Sell
12,660
-13,310
-51% -$97.5K ﹤0.01% 5379
2025
Q3 		$229K Buy
25,970
+12,120
+88% +$107K ﹤0.01% 4775
2025
Q2 		$96K Buy
+13,850
New +$127K ﹤0.01% 5277
2025
Q1 		– Sell
-930
Closed -$9K – 9011
2024
Q4 		$9K Sell
930
-290
-24% -$3.65K ﹤0.01% 7262
2024
Q3 		$20K Buy
1,220
+300
+33% +$4.27K ﹤0.01% 6671
2024
Q2 		$10K Sell
920
-350
-28% -$4.35K ﹤0.01% 7423
2024
Q1 		$16K Sell
1,270
-710
-36% -$9.23K ﹤0.01% 7267
2023
Q4 		$29K Buy
1,980
+810
+69% +$9.92K ﹤0.01% 6592
2023
Q3 		$17K Sell
1,170
-880
-43% -$16.9K ﹤0.01% 6757
2023
Q2 		$51K Buy
2,050
+800
+64% +$13.4K ﹤0.01% 5824
2023
Q1 		$18K Buy
1,250
+650
+108% +$12.1K ﹤0.01% 7008
2022
Q4 		$8K Sell
600
-1,020
-63% -$27.8K ﹤0.01% 7729
2022
Q3 		$51K Sell
1,620
-980
-38% -$41K ﹤0.01% 6421
2022
Q2 		$90K Sell
2,600
-10,770
-81% -$690K ﹤0.01% 5706
2022
Q1 		$1.51M Buy
13,370
+12,010
+883% +$1.39M ﹤0.01% 2397
2021
Q4 		$130K Buy
1,360
+740
+119% +$66.6K ﹤0.01% 5830
2021
Q3 		$80K Hold
620
– – ﹤0.01% 6929
2021
Q2 		$76K Buy
620
+615
+12,300% +$85.1K ﹤0.01% 7110
2021
Q1 		$81K Sell
5
-15
-75% -$2.54K ﹤0.01% 6032
2020
Q4 		$308K Buy
20
+6
+43% +$1.08K ﹤0.01% 4031
2020
Q3 		$250K Buy
+14
New +$2.29K ﹤0.01% 3823
2019
Q3 		– Sell
-41
Closed -$467K – 7536
2019
Q2 		$467K Buy
+41
New +$5.39K ﹤0.01% 2629
2018
Q4 		– Sell
-1
Closed -$14K – 7370
2018
Q3 		$14K Buy
+1
New +$2.61K ﹤0.01% 6225
2018
Q2 		– Hold
0
– – – 4741
2018
Q1 		– Hold
0
– – – 4482
2017
Q4 		– Hold
0
– – – 4501
2016
Q2 		– Sell
-1
Closed -$44K – 6090
2016
Q1 		$44K Buy
+1
New +$3.47K ﹤0.01% 2064
2015
Q4 		– Hold
0
– – – 2383
2015
Q3 		– Hold
0
– – – 3843
2015
Q2 		– Hold
0
– – – 4678

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Simplex Trading's IMUX Position: Q4 2025 in Review

Simplex Trading sold out of Immunic (IMUX) in Q4 2025, closing a stake of 438 shares — an estimated $3.21K sold.

Simplex Trading first reported a position in IMUX in Q4 2015 and held it in 21 quarters. The position peaked at $124K in Q1 2025. 58 funds tracked by Wall St. Rank hold IMUX as of Q4 2025.

  • Simplex Trading reported no remaining Immunic position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 438 Immunic shares in Q4 2025, an estimated $3.21K.
  • Simplex Trading first reported a position in Immunic in Q4 2015 and held it in 21 quarters.
  • Simplex Trading's Immunic position peaked at $124K in Q1 2025.
  • 58 funds tracked by Wall St. Rank held Immunic as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.